The Street

Although Tesla Inc (NASDAQ: TSLA) CEO Elon Musk is the richest person in the world, he may not be as smart as some of his billionaire peers, according to new data used to assess general intelligence. What To Know: According to a report from The Street citing online tutoring...

Fed Chairman Jerome Powell said on Monday that inflation is too high and that the FED is ready to take action as needed. Powell’s tone has shifted tremendously since last year, when he described the inflation we were seeing as "transitory," meaning that it would soon pass. ...

Soros Fund Management, the private investment firm of billionaire George Soros, is now trading Bitcoin (CRYPTO: BTC) and considering acquiring crypto and blockchain companies. What Happened: According to The Street, over the last few weeks, Soros Fund Management's Chief...

Canopy Growth Corp (NYSE: CGC) shares surged more than 4 percent after co-CEO Bruce Linton updated the company’s fiscal 2020 revenue guidance Tuesday at the GMP Securities cannabis conference in Toronto.  What Happened Canopy anticipates at least $744 million in revenue in...

Since 1980, tens of thousands of cyclists have ridden in the Pan-Mass Challenge to raise a total of $547 million for the Jimmy Fund of the Dana-Farber Cancer Institute. The race proceeds are the Institute's greatest contribution and comprise more than 50 percent of the Jimmy Fund’s annual...

TherapeuticsMD Inc (NYSE: TXMD) has waned as much as 40 percent since April 7, when the company received an FDA letter noting deficiencies in the new drug application for vulvovaginal atrophy treatment, Yuvvexy (TX-004HR). The regulatory agency said the deficiencies preclude talk of the drugs...

When people talk Gilead Sciences, Inc. (NASDAQ: GILD) takeover possibilities, TESARO Inc (NASDAQ: TSRO) and Incyte Corporation (NASDAQ: INCY) commonly surface. But biotech reporter Adam Feuerstein posited a less conventional interest — orphan-drug company BioMarin Pharmaceutical Inc. (NASDAQ...

Shares of Amgen, Inc. (NASDAQ: AMGN) fell 7 percent after the biotechnology company released data from its therapy called Repatha, which is used to lower the risk of heart attacks, strokes and heart problems. Amgen reported Repatha reduces the risk of heart attacks, stokes and other heart-related...

Nintendo Co., Ltd (ADR) (OTC: NTDOY) may have hit the jackpot with its " Super Mario Run," as it launched its first full-blown mobile game Thursday. The Japanese company has had its fair share of success as a video gaming console company. Having started out as an unparalleled leader, the company...

Chipotle Mexican Grill, Inc. (NYSE: CMG) opened Tuesday’s session down more than 7.5 percent following yet another disappointing quarterly report. Disappointment Continues A number of food safety issues plagued the company throughout late 2015 and early 2016, including multiple...

Wedbush’s Christopher Svezia believes a 13 percent premium multiple is justified for Foot Locker, Inc. (NYSE: FL), given the company’s “global dominance in athletic footwear and the ability to navigate and adapt to consumer preferences.” Svezia initiated coverage of the...

Professional investors spend over $600 million per year speaking with the most qualified experts before risking their capital. Until now, this information was unavailable to most investors. But Slingshot Insights is trying to change that by offering every investor access to the same insiders...

The Street's retail expert Brian Sozzi agrees with the latest downgrade to hit Best Buy Co Inc (NYSE: BBY). Jefferies' Dan Binder downgraded Best Buy's stock to Hold from Buy on Monday due to his concerns that a maturing 4K TV cycle will yield softer same-store sales and margins at...

Andrew Left and his research firm, Citron Research, are known for short selling overvalued or over-hyped companies. Left led the bearish case against Valeant Pharmaceuticals Intl Inc (NYSE: VRX) and even referred to the company as the "Enron" of the pharmaceutical industry back in...